Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

Cell Reports(2021)10.1016/j.celrep.2021.109549Source: DataRank Database

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

gen uniprot nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (32 grants)OA: goldTopics (74)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Lingegowda S. Mangala,Wen Hu ORCID,Emine Bayaktar,Akira Yokoi ORCID,Wei Hu ORCID

Live enrichment

PubMed:34407412 PMC:PMC8422976

National Cancer Institute

Grant: ACN15006-001

National Cancer Institute

Grant: P50CA217685

National Cancer Institute

Grant: P30CA016672

National Cancer Institute

Grant: R35CA209904

Women's Cancer Research Foundation

Grant: 5T32CA009599

Women's Cancer Research Foundation

Grant: FP00009883

National Institutes of Health

Grant: UH3TR000943

U.S. Department of Energy

Grant: DE-AC05-76RL01830

U.S. Department of Energy

Grant: NIHP30CA016672

NCI NIH HHS

Grant: P30 CA240139

NCI NIH HHS

Grant: U01 CA213759

NCI NIH HHS

Grant: U54 CA096300

NCI NIH HHS

Grant: R01 CA124723

NCI NIH HHS

Grant: U54 CA096297

NCI NIH HHS

Grant: T32 CA009599

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 5U54CA096300-02

PRCC/MDACC: Partners for Excellence in Cancer Research

National Institutes of Health

Grant: 3UH3TR000943-04S1

Novel extra cellular RNA-based combinatorial RNA inhibition therapy

National Institutes of Health

Grant: 1R35CA209904-01A1

Harnessing the power of exosomes for non-coding RNA delivery

National Institutes of Health

Grant: 5T32CA009599-19

Training of Academic Surgical Oncologists

National Institutes of Health

Grant: 1P50CA217685-01

U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer

Clovis Oncology

American Cancer Society

AbbVie

Genentech

Janssen Pharmaceuticals

Ovarian Cancer Research Fund Alliance

Merck

AstraZeneca

Ovarian Cancer Research Alliance

Pacific Northwest National Laboratory

University of Texas MD Anderson Cancer Center

goldLicense: CC BY NC ND

publisherhttp://www.cell.com/article/S2211124721009839/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124721009839?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721009839?httpAccept=text/plain

repositoryhttps://www.osti.gov/biblio/1836250

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8422976

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciencesAgedAnimalsBevacizumabCell Line, TumorCell ProliferationDisease Models, AnimalExtracellular VesiclesFemaleHumansMiceMice, NudeMiddle AgedNeovascularization, PathologicOvarian NeoplasmsProtein IsoformsSignal TransductionTetraspanin 30Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

MeSH Terms

Cell Line, TumorAnimalsHumansMiceMice, NudeOvarian NeoplasmsDisease Models, AnimalNeovascularization, PathologicVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor AProtein IsoformsSignal TransductionCell ProliferationAgedMiddle AgedFemaleExtracellular VesiclesBevacizumabTetraspanin 30

Keywords

Drug resistanceAngiogenesisVEGFBevacizumabExtracellular VesiclesCd63Vascular Endothelial Growth Factor AMice, NudeExosomesOvarian-CancerTrialArticleMiceCell Line, TumorOceansMechanismsChemotherapyAnimalsHumansProtein IsoformsEndothelial Growth-FactorAgedCell ProliferationOvarian NeoplasmsNeovascularization, PathologicTetraspanin 30Middle AgedIntracrine VegfVascular Endothelial Growth Factor Receptor-2Disease Models, AnimalFemaleRecurrentSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good health

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

FAIR Checklist

Authors (24)

Funding (32 grants)

Open Access

Topics

Annotations (Europe PMC)